- #1
Kathe
- 30
- 0
Hi, I have a doubt about calculating the solubility of lamivudine (3TC). Suppose you have an excess of free base lamivudine (B) in solution. An equilibrium is generated between B in the aqueous phase and B in the solid phase, i.e. in solution and the base body. As we acidify the pH by progressive addition of blood, meanwhile, it will be dissociated, according to its acid / base balance, to dare BH +. The maximum concentration of B in water, for [BH +] ~ 0 (even if the 0 in chemistry nn exists) is precisely the intrinsic solubility, S0. Total solubility, as it is known, for pH> 4.5 is ST = + [BH +] = S0 + S0 * [H3O +] / Ka = S0 * (1+ [H3O +] / Ka). Solubility for pH <3 is ST = + [BH +] = (Kps 1: 1) ^ 1/2 + [(Kps 1: 1) ^ 1/2 * (Ka / [H3O +])] = (Kps 1: 1) ^ 1/2 * [(1 + Ka / [H3O +])].
My problem is that this does not set the equation for 3<pH <4.5. For pH = pKa = 4.2 we have that = [BH +] = 2 * (Kps 2: 1) ^ 1/3 = 2 * (5.3 * 10 ^ -4 M ^ 3) ^ 1/3 = 2 * 0.08 = 0.16 ... is it correct?
But for pH between 3 and 4.5, how is solubility calculated? I have hypothesized that, the total solubility, the mass balance, is the sum of all the concentrations of the forms in which lamivudine is present in solution, ie as a free base, conjugated acid and sale, then it could be + [ BH +] + [BHB +] or by applying the concept of cationic dimer could be + [BH +] + 2 [BHB +] (in this case it would multiply by 2 to take into account the degree of aggregation.
In both cases I don't find myself with the fact that the solubility between 4.5 and 3 goes down sale that has stoichiometry different from the usual 1: 1 In our case we have the presence of a partial sale 2: 1 that lowers the solubility. n = 2) also because , in this case, I would have to obscure the equilibrium constant of the dimer (K2), instead I only know the Kps 2: 1.
In this case K2 = Kps 2: 1?
Moreover if I consider BHB if this was in equilibrium with 2B + [H +] we have that (kps 2: 1) = (2s) ^ 2 * s = 4s ^ 3 if if BHB + was in equilibrium with B + BH + then (Kps2: 1) would be equal as * s = s ^ 2. however, there is also Cl- [BH +] [Cl -] = s ^ 3. Furthermore, what will B be equal to? If nn erro B = s only at pH = pka if I'm not mistaken. I'm going into the ball. KCl is used to assess the effect of the ion in fact a common presence of Clase plus solubility. I enclose the graphic image taken from the first edition of the book "the practice of pharmaceutical chemistry" (or better, from its translation in Italian). Thanks in advance and good day or all of you in the forum.
My problem is that this does not set the equation for 3<pH <4.5. For pH = pKa = 4.2 we have that = [BH +] = 2 * (Kps 2: 1) ^ 1/3 = 2 * (5.3 * 10 ^ -4 M ^ 3) ^ 1/3 = 2 * 0.08 = 0.16 ... is it correct?
But for pH between 3 and 4.5, how is solubility calculated? I have hypothesized that, the total solubility, the mass balance, is the sum of all the concentrations of the forms in which lamivudine is present in solution, ie as a free base, conjugated acid and sale, then it could be + [ BH +] + [BHB +] or by applying the concept of cationic dimer could be + [BH +] + 2 [BHB +] (in this case it would multiply by 2 to take into account the degree of aggregation.
In both cases I don't find myself with the fact that the solubility between 4.5 and 3 goes down sale that has stoichiometry different from the usual 1: 1 In our case we have the presence of a partial sale 2: 1 that lowers the solubility. n = 2) also because , in this case, I would have to obscure the equilibrium constant of the dimer (K2), instead I only know the Kps 2: 1.
In this case K2 = Kps 2: 1?
Moreover if I consider BHB if this was in equilibrium with 2B + [H +] we have that (kps 2: 1) = (2s) ^ 2 * s = 4s ^ 3 if if BHB + was in equilibrium with B + BH + then (Kps2: 1) would be equal as * s = s ^ 2. however, there is also Cl- [BH +] [Cl -] = s ^ 3. Furthermore, what will B be equal to? If nn erro B = s only at pH = pka if I'm not mistaken. I'm going into the ball. KCl is used to assess the effect of the ion in fact a common presence of Clase plus solubility. I enclose the graphic image taken from the first edition of the book "the practice of pharmaceutical chemistry" (or better, from its translation in Italian). Thanks in advance and good day or all of you in the forum.
Attachments
Last edited by a moderator: